PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
68.40
+5.58 (8.88%)
At close: Mar 9, 2026, 4:00 PM EDT
68.60
+0.20 (0.29%)
After-hours: Mar 9, 2026, 5:32 PM EDT
PTC Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 5,662 | 6,099 | 3,481 | 2,080 | 2,786 | 2,816 | |
| Market Cap Growth | 45.71% | 75.18% | 67.40% | -25.35% | -1.06% | -32.38% | |
| Enterprise Value | 6,423 | 6,883 | 4,940 | 3,253 | 3,671 | 3,207 | |
| Last Close Price | 68.40 | 75.96 | 45.14 | 27.56 | 38.17 | 39.83 | |
| PE Ratio | 8.79 | 8.93 | - | - | - | - | |
| PS Ratio | 3.27 | 3.52 | 4.32 | 2.22 | 3.99 | 5.23 | |
| PB Ratio | - | -29.70 | -3.17 | -2.54 | -8.03 | 1958.20 | |
| P/FCF Ratio | 8.06 | 8.68 | - | - | - | - | |
| P/OCF Ratio | 7.96 | 8.57 | - | - | - | - | |
| EV/Sales Ratio | 3.71 | 3.98 | 6.12 | 3.47 | 5.25 | 5.95 | |
| EV/EBITDA Ratio | 7.17 | 7.69 | - | - | - | - | |
| EV/EBIT Ratio | 7.50 | 8.04 | - | - | - | - | |
| EV/FCF Ratio | 9.15 | 9.80 | - | - | - | - | |
| Debt / Equity Ratio | -13.18 | -13.18 | -2.25 | -2.72 | -4.21 | 882.73 | |
| Debt / EBITDA Ratio | 2.95 | 2.95 | - | - | - | - | |
| Debt / FCF Ratio | 3.85 | 3.85 | - | - | - | - | |
| Net Debt / Equity Ratio | -3.71 | -3.71 | -1.20 | -1.64 | -3.03 | 344.92 | |
| Net Debt / EBITDA Ratio | 0.85 | 0.85 | -18.54 | -11.93 | -3.38 | -1.60 | |
| Net Debt / FCF Ratio | 1.09 | 1.09 | -11.54 | -7.20 | -2.70 | -1.77 | |
| Asset Turnover | 0.75 | 0.75 | 0.45 | 0.52 | 0.38 | 0.26 | |
| Inventory Turnover | 9.77 | 9.77 | 22.02 | 27.95 | 36.97 | 33.17 | |
| Quick Ratio | 2.20 | 2.20 | 2.26 | 1.90 | 1.39 | 1.74 | |
| Current Ratio | 2.35 | 2.35 | 2.35 | 2.02 | 1.71 | 1.87 | |
| Return on Equity (ROE) | - | - | - | - | - | -216.75% | |
| Return on Assets (ROA) | 23.26% | 23.26% | -5.09% | -12.13% | -15.09% | -11.30% | |
| Return on Invested Capital (ROIC) | 141.62% | 216.34% | -39.27% | -56.75% | -73.25% | -76.84% | |
| Return on Capital Employed (ROCE) | 44.40% | 44.40% | -13.10% | -27.00% | -33.90% | -26.20% | |
| Earnings Yield | 12.06% | 11.19% | -10.44% | -30.13% | -20.06% | -18.61% | |
| FCF Yield | 12.40% | 11.52% | -3.28% | -8.98% | -13.95% | -9.93% | |
| Buyback Yield / Dilution | -14.92% | -14.92% | -2.68% | -4.33% | -1.79% | -6.72% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.